Soligenix, Inc. (SNGX) financial statements (2022 and earlier)

Company profile

Business Address 29 EMMONS DRIVE
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26,04418,6775,4218,9847,8098,7734,922
Cash and cash equivalents26,04418,6775,4218,9847,8098,7734,922
Receivables2432041,0191,2021,3431,2071,985
Prepaid expense283225610157263134244
Deferred costs  39    
Other undisclosed current assets 361405    
Total current assets:26,57019,4677,49310,3439,41610,1147,151
Noncurrent Assets
Finance lease, right-of-use asset 6 
Property, plant and equipment22243620372747
Intangible assets, net (including goodwill)  204774127189
Intangible assets, net (excluding goodwill)  204774127189
Capitalized contract cost, net121   
Deposits noncurrent assets2323232323  
Assets held-in-trust106228125    
Deferred costs20      
Other noncurrent assets82339    
Other undisclosed noncurrent assets 1213960   
Total noncurrent assets:300424282149134153236
TOTAL ASSETS:26,87019,8917,77510,4929,55010,2677,387
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,1855,6436,1914,2123,2302,8704,679
Accounts payable2,9262,1302,7352,1261,7541,7084,380
Accrued liabilities2,9572,6383,1571,7911,143806 
Employee-related liabilities303875298295333356299
Debt 331    293
Derivative instruments and hedges, liabilities      2,434
Other undisclosed current liabilities106106121    
Total current liabilities:6,2916,0816,3124,2123,2302,8707,405
Noncurrent Liabilities
Long-term debt and lease obligation 93     
Long-term debt, excluding current maturities 93     
Other undisclosed noncurrent liabilities9,8569,9766    
Total noncurrent liabilities:9,85610,0696    
Total liabilities:16,14716,1496,3184,2123,2302,8707,405
Stockholders' equity
Stockholders' equity attributable to parent10,7233,7421,4576,2806,3207,397(18)
Common stock433122189531
Additional paid in capital216,403196,950177,006172,436163,581157,515146,828
Accumulated other comprehensive income (loss)42(24)(45)(4)   
Accumulated deficit(205,765)(193,214)(175,526)(166,170)(157,270)(150,123)(146,878)
Total stockholders' equity:10,7233,7421,4576,2806,3207,397(18)
TOTAL LIABILITIES AND EQUITY:26,87019,8917,77510,4929,55010,2677,387

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues8242,3594,6305,2415,43210,4498,768
Revenue, net5,43210,4498,768
Cost of revenue(729)(1,821)(3,567)(4,598)(4,310)(8,434)(6,882)
Gross profit:965381,0636441,1222,0151,886
Operating expenses(13,237)(19,125)(11,604)(9,703)(8,716)(7,725)(8,996)
Operating loss:(13,141)(18,587)(10,541)(9,059)(7,594)(5,710)(7,110)
Nonoperating income (expense)(314)(23)157159301,934(1,210)
Investment income, nonoperating  149159301,541 
Foreign currency transaction gain (loss), before tax(39)(23)8    
Other nonoperating expense(275)      
Interest and debt expense(0)(62)(7)    
Other undisclosed income from continuing operations before equity method investments, income taxes 146425    
Loss from continuing operations before equity method investments, income taxes:(13,455)(18,525)(9,966)(8,900)(7,564)(3,776)(8,320)
Other undisclosed income from continuing operations before income taxes40      
Loss from continuing operations before income taxes:(13,416)(18,525)(9,966)(8,900)(7,564)(3,776)(8,320)
Income tax benefit865837611 417530489
Net loss available to common stockholders, basic:(12,551)(17,689)(9,356)(8,900)(7,147)(3,245)(7,831)
Other undisclosed net loss available to common stockholders, diluted     (1,541) 
Net loss available to common stockholders, diluted:(12,551)(17,689)(9,356)(8,900)(7,147)(4,787)(7,831)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(12,551)(17,689)(9,356)(8,900)(7,147)(3,245)(7,831)
Comprehensive loss:(12,551)(17,689)(9,356)(8,900)(7,147)(3,245)(7,831)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent6621(41)(4)   
Comprehensive loss, net of tax, attributable to parent:(12,485)(17,668)(9,397)(8,904)(7,147)(3,245)(7,831)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: